Rigel Pharmaceuticals (RIGL)

Add to Watchlists
Create an Alert
3.40 -0.16  -4.49% NASDAQ Dec 18, 13:20 Delayed 2m USD

Rigel Pharmaceuticals Total Liabilities (Quarterly):

15.08M for Sept. 30, 2017
View 4,000+ financial data types
Browse...
View Full Chart

Rigel Pharmaceuticals Total Liabilities (Quarterly) Chart

Export Data
Save Image
Print Image

Rigel Pharmaceuticals Historical Total Liabilities (Quarterly) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2017 15.08M
June 30, 2017 15.87M
March 31, 2017 17.24M
Dec. 31, 2016 23.11M
Sept. 30, 2016 22.70M
June 30, 2016 25.60M
March 31, 2016 32.83M
Dec. 31, 2015 40.37M
Sept. 30, 2015 42.76M
June 30, 2015 47.20M
March 31, 2015 53.54M
Dec. 31, 2014 25.89M
Sept. 30, 2014 16.37M
June 30, 2014 16.70M
March 31, 2014 14.96M
Dec. 31, 2013 17.81M
Sept. 30, 2013 16.14M
June 30, 2013 16.62M
March 31, 2013 17.63M
Dec. 31, 2012 20.95M
Sept. 30, 2012 19.51M
June 30, 2012 18.61M
March 31, 2012 17.33M
Dec. 31, 2011 20.96M
Sept. 30, 2011 17.90M
   
June 30, 2011 17.18M
March 31, 2011 16.36M
Dec. 31, 2010 20.56M
June 30, 2010 71.48M
March 31, 2010 124.36M
Dec. 31, 2009 30.88M
Sept. 30, 2009 33.99M
June 30, 2009 36.67M
March 31, 2009 37.06M
Dec. 31, 2008 39.69M
Sept. 30, 2008 37.84M
June 30, 2008 32.47M
March 31, 2008 28.42M
Dec. 31, 2007 33.61M
Sept. 30, 2007 25.36M
June 30, 2007 23.90M
March 31, 2007 24.62M
Dec. 31, 2006 26.01M
Sept. 30, 2006 24.94M
June 30, 2006 25.93M
March 31, 2006 34.68M
Dec. 31, 2005 39.08M
Sept. 30, 2005 32.14M
June 30, 2005 34.47M
March 31, 2005 35.59M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Total Liabilities

Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More

Advertisement

RIGL Total Liabilities (Quarterly) Benchmarks

Benchmarks
Endocyte 5.092M
Catabasis Pharmaceuticals 7.656M
CytomX Therapeutics 341.56M

RIGL Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 14.96M Mar 2014
Maximum 53.54M Mar 2015
Average 24.97M

RIGL Total Liabilities (Quarterly) Excel Add-In Codes

  • Metric Code: liabilities
  • Latest data point: =YCP("RIGL", "liabilities")
  • Last 5 data points: =YCS("RIGL", "liabilities", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.